Valuation: Dil Ltd

Market Cap 9.39B 97.51M 97.51M 85.21M 78.63M 72.48M 137M 140M 940M 370M 4.6B 366M 358M 15.83B P/E 2024
-18.9x
P/E 2025 10.4x
Enterprise Value 9.83B 102M 102M 89.23M 82.34M 75.89M 143M 146M 984M 387M 4.82B 383M 375M 16.58B EV / Sales 2024
1.54x
EV / Sales 2025 1.81x
Free-Float
25.84%
Yield 2024
0.83%
Yield 2025 0.91%
Manager TitleAgeSince
Chief Executive Officer 56 09/05/2021
Director of Finance/CFO - 16/02/2017
Compliance Officer - 12/02/2024
Director TitleAgeSince
Director/Board Member 56 12/08/2022
Director/Board Member 44 22/06/2011
Director/Board Member 75 29/12/2009
Change 5-day change 1-year change 3-year change Capi.($)
-0.33%+1.83%+23.03%-6.22% 68.85B
+0.67%+0.93%+37.53%+198.53% 52.13B
+0.94%+39.60%+39.60%+39.60% 43.46B
+1.12%+0.35%-50.35%-52.35% 41.24B
-1.40%+3.43%+60.07%-26.01% 30.41B
-2.11%-9.45%+91.99%-49.58% 24.53B
+0.51%+0.46%+70.08%+91.96% 23.42B
-5.57%-0.84%-0.17%+174.11% 19.75B
-0.86%-1.99%+68.42%+124.39% 16.57B
Average -0.78%-0.81%+37.80%+54.94% 35.6B
Weighted average by Cap. -0.34%-0.07%+31.34%+47.23%

Financials

2024 2025
Net sales 3.36B 34.86M 34.86M 30.46M 28.11M 25.91M 48.83M 49.92M 336M 132M 1.64B 131M 128M 5.66B 4.69B 48.75M 48.75M 42.6M 39.31M 36.24M 68.3M 69.82M 470M 185M 2.3B 183M 179M 7.92B
Net income -231M -2.39M -2.39M -2.09M -1.93M -1.78M -3.35M -3.43M -23.08M -9.08M -113M -8.99M -8.8M -389M 769M 7.98M 7.98M 6.97M 6.44M 5.93M 11.18M 11.43M 76.93M 30.26M 376M 29.97M 29.32M 1.3B
Net Debt 789M 8.2M 8.2M 7.16M 6.61M 6.09M 11.48M 11.74M 79.01M 31.08M 387M 30.79M 30.11M 1.33B 443M 4.6M 4.6M 4.02M 3.71M 3.42M 6.44M 6.58M 44.32M 17.43M 217M 17.27M 16.89M 746M
Logo Dil Ltd
Fermenta Biotech Limited is an India-based company that is engaged in the manufacturing of vitamin D, active pharmaceutical ingredients (APIs), enzymes and providing environmental solutions services. It is also engaged in renting and selling properties. Its segments include Chemicals/Bulk Drug and Property. The Chemicals/Bulk Drug segment is engaged in the manufacturing and selling of chemicals, primarily bulk drugs and enzymes. The Property segment is involved in renting and sale of properties. It has a diverse range of products and services that cater to various industries, such as pharmaceuticals, dietary and nutritional supplements, food and beverage fortification, animal feed, veterinary and others. It provides proprietary specialized technologies through its enzyme portfolio across the biopharmaceutical product life cycle. It also offers a range of nutritional ingredients, such as fish oil-derived cholesterol for aquaculture nutrition, and vitamin AD2 premix, among others.
Employees
-